Search

The article presents the discussion on behavioral treatments working for migraine prevention. Topics include providing separate estimates for each dose and route of administration of each triptan; resulting from progressive muscle relaxation, autogenic training, behavioral management, cognitive behavioral therapy (CBT), biofeedback, mindfulness-based interventions, and hypnosis; and cognitive behavioral therapies leading to reductions in attacking frequency and disability.

The article offers information on various factors related to headaches and migraines, including lifestyle, diet, dietary triggers, caffeine, and sleep. It discusses the impact of diet and nutrition on headaches, the relationship between alcohol and migraines, the complex relationship between caffeine and headaches, and the potential benefits of dietary nutrients such as riboflavin, magnesium, thiamine, and coenzyme Q10.

An editorial is presented in which author discusses new guidelines of migraine. Topics discussed include information on guidelines from American Academy of Neurology (AAN) in collaboration with specialty societies has developed a growing number of evaluation and treatment guidelines; challenges of guideline development like finding strength of the evidence of efficacy; and use of the standardized approach of the guideline development.

An editorial is presented on the nationwide population-based survey to analyze the correlation between dietary intake of two essential substances, thiamine and riboflavin, and reduced burden of headache, likely migraine, in a large and diverse population. It outlines the limitations inherent in dietary review by recall, which include reduced accuracy compared to much more onerous observed or prescribed diet studies. An overview of the category of migraine is presented.

The article offers information on the hypothesis for migraine progression in which risk factors are linked to persistent activation of the trigeminovascular pathway. It discussed prevention and treatment of chronic migraine (CM) that may be achieved through interventions which prevent trigeminovascular activation.

An editorial is presented on the approach on understanding latitudinal differences in migraine epidemiology. It expresses the view that the philosophy of migraine affects the way individuals and the society respond to the condition at the same time. It notes flexibility, adaptability, analysis, expectations, decision making, and locus of control are all dependent on how the condition is viewed.

The article focuses on migraine knowledge gaps among women's healthcare providers. Topics discussed include the preventive treatments prescribed for migraine such as antidepressants and anticonvulsants; hormone therapies in reducing migraine and migraine as the leading cause of visits to the emergency room among women of childbearing age.

An editorial is presented that discussed about the development of the Pediatric Migraine Action Plan (PedMAP) which was first introduced in February 2018. It mentions the MAP's essential elements of a plan including a specific headache diagnosis, a preventive treatment plan, a home acute treatment strategy.

An introduction is presented in which the editor discusses articles in the issue on topics including acute treatment of migraine attacks, use of target calcitonin gene-related peptide (CGRP) for migraine, and clinical trials of 5HT-1F receptor agonists.

An introduction is presented in which editor discusses various articles within the issue on topics including science of Calcitonin Gene-Related Peptide (CGRP), how monoclonal antibodies work to help migraine patients and monoclonal antibodies against CGRP receptor.

An introduction to the journal is presented in which the guest editors discuss the updated evidence criteria for the treatment of migraine based on the "Pharmacological Management of Acute Attacks" guidelines from the American Academy of Neurology (AAN) and the American Headache Society (AHS).

The article focuses on a controversy related to the article "Efficacy of gabapentin in migraine prophylaxis" by N.T. Mathew and colleagues in a previous issue. Mathew and colleagues do not desire to retract the above article and deny any misrepresentation on their part. The data analysis for the article consisted of an intention-to-treat analysis performed on a research group from which some patients had been deleted instead of the pre-specified primary outcome measure.

An introduction is presented in which the editor discusses various reports within the issue on topics involving migraine attack predictors and triggers.